It basically consists in medically grafting live rejuvenated tissue in the form of autologous adipose adult stem cells to a damaged organ in order to restore it and improve its function.
[2] The remarkable results improved current prognosis on patients who required a liver transplant but even then there were far from meeting the demand and many hundreds to this date die waiting for a donor.
[5] More recently he has determined the safety on fat derived stem cells for breast reconstruction after mastectomy as long as there is no evidence of cancer.
In 2008, after years of research the University of Pittsburgh and the UCLA come together sharing their progress in order to the develop a viable stem cell treatment.
[12][13][14][15] In 2009 at the University of Tokyo he was able to determine the adequate pressure for grafting ADSC more effectively, paving the road to diverse applications for the future.
After this breakthrough the engraftment rate was improved even further thanks to the development of a nanoscale shielding using biomaterials approved by the U.S. Food and Drug Administration (FDA).
The concept of the MIRA procedure can be considered more off as a minimally invasive tissue graft which function restoring capabilities work under the principles of adult stem cells.
Currently the MIRA Procedure is most well known as an alternative to cosmetic surgery but has proved to be successful in restoring health to patients with chronic heart disease and cirrhotic liver.